OTC Rules Seen Benefiting Goldman
New rules governing over-the-counter derivatives and commodity treading are seen benefiting tech-savvy Goldman Sachs, according to Keith Horowitz, a Citigroup analyst.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
